|
BRAF expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.836300E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.511700E-02 |
| Normal-vs-Stage2 |
3.077800E-02 |
| Normal-vs-Stage3 |
6.170200E-04 |
| Normal-vs-Stage4 |
4.466200E-02 |
| Stage1-vs-Stage2 |
4.501600E-01 |
| Stage1-vs-Stage3 |
3.036400E-02 |
| Stage1-vs-Stage4 |
5.630400E-01 |
| Stage2-vs-Stage3 |
3.842000E-01 |
| Stage2-vs-Stage4 |
8.867000E-01 |
| Stage3-vs-Stage4 |
2.956800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.783920E-02 |
| Normal-vs-AfricanAmerican |
4.072000E-01 |
| Normal-vs-Asian |
1.066140E-02 |
| Caucasian-vs-AfricanAmerican |
5.539400E-01 |
| Caucasian-vs-Asian |
3.806400E-01 |
| AfricanAmerican-vs-Asian |
2.431400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.195340E-03 |
| Normal-vs-Female |
3.006400E-02 |
| Male-vs-Female |
6.731600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.118400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.520400E-03 |
| Normal-vs-Age(61-80Yrs) |
1.613630E-02 |
| Normal-vs-Age(81-100Yrs) |
3.297500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.062100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.760210E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.476010E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.096400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.149360E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.180240E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.358100E-02 |
| Classical-VS-Follicular |
1.846200E-01 |
| Classical-VS-Other |
7.056000E-01 |
| Classical-VS-Normal |
6.484300E-02 |
| Tall-VS-Follicular |
4.160600E-01 |
| Tall-VS-Other |
5.694600E-01 |
| Tall-VS-Normal |
2.360800E-03 |
| Follicular-VS-Other |
9.503600E-01 |
| Follicular-VS-Normal |
1.169960E-02 |
| Other-VS-Normal |
2.173200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.794500E-04 |
| Normal-vs-N1 |
1.133580E-01 |
| N0-vs-N1 |
3.926600E-01 |
|
|
